Santarus(R) and ZEGERID(R) are trademarks of Santarus, Inc. Naprelan(R) is a registered trademark of Elan Corporation, plc. Fleet(R) is a trademark of CB ...
Santarus® and ZEGERID® are trademarks of Santarus, Inc. Naprelan® is a registered trademark of Elan Corporation, plc. Fleet® is a trademark of CB Fleet ...
NAPRELAN (naproxen sodium) Controlled Release Tablets are commercially available in 375 mg and 500 mg dosage strengths. NAPRELAN Tablets use Elan's ...
Santarus shares jumped on Friday after the company reported it is co-promoting Naprelan, a once-daily high-dose formulation of pain reliever naproxen. ...
Victory Pharma, a privately held San Diego company, said it had acquired the exclusive US marketing rights to Naprelan, the only once-a-day branded ...
Victory Pharma, a privately held San Diego company, said it had acquired the exclusive US marketing rights to Naprelan, the only once-a-day branded ...